{"id":"https://openalex.org/W2005236814","doi":"https://doi.org/10.1016/j.jpba.2011.01.002","title":"Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate","display_name":"Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate","publication_year":2011,"publication_date":"2011-01-20","ids":{"openalex":"https://openalex.org/W2005236814","doi":"https://doi.org/10.1016/j.jpba.2011.01.002","mag":"2005236814","pmid":"https://pubmed.ncbi.nlm.nih.gov/21316175"},"language":"en","primary_location":{"id":"doi:10.1016/j.jpba.2011.01.002","doi":"https://doi.org/10.1016/j.jpba.2011.01.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jpba.2011.01.002","pdf_url":null,"source":{"id":"https://openalex.org/S174893293","display_name":"Journal of Pharmaceutical and Biomedical Analysis","issn_l":"0731-7085","issn":["0731-7085","1873-264X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical and Biomedical Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084439917","display_name":"Sreenivasa Rao Chitturi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sreenivasa Rao Chitturi","raw_affiliation_strings":["APL Research Centre, Aurobindo Pharma Limited, Hyderabad, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre, Aurobindo Pharma Limited, Hyderabad, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053707333","display_name":"Yallappa Somappa Somannavar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Yallappa Somappa Somannavar","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071765752","display_name":"P. Badarinadh Gupta","orcid":"https://orcid.org/0000-0003-0367-0512","observed_orcids":["https://orcid.org/0000-0003-0367-0512"]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Badarinadh Gupta Peruri","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018636431","display_name":"Sreenivas Nallapati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sreenivas Nallapati","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hemant Kumar Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Hemant Kumar Sharma","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035228849","display_name":"Shankar Reddy Budidet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Shankar Reddy Budidet","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111671291","display_name":"Vijay Kumar Handa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110833","display_name":"Aurobindo Pharma (India)","ror":"https://ror.org/01wzc4m50","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210110833"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vijay Kumar Handa","raw_affiliation_strings":["APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"APL Research Centre (A Division of Aurobindo Pharma Limited), 313, Bachupally, Hyderabad 500 090, Andhra Pradesh, India","institution_ids":["https://openalex.org/I4210110833"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018398204","display_name":"Hima Bindu Vurimindi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I10874241","display_name":"Jawaharlal Nehru Technological University, Hyderabad","ror":"https://ror.org/002tchr49","country_code":"IN","type":"education","lineage":["https://openalex.org/I10874241"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Hima Bindu Vurimindi","raw_affiliation_strings":["Centre for Environment, Institute of Science and Technology, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad 500 085, Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Environment, Institute of Science and Technology, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad 500 085, Andhra Pradesh, India","institution_ids":["https://openalex.org/I10874241"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3680,"currency":"USD","value_usd":3680},"apc_paid":null,"fwci":1.754,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.80813194,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"55","issue":"1","first_page":"31","last_page":"47"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/process-related-impurities","display_name":"process-related impurities","score":0.859000027179718},{"id":"https://openalex.org/keywords/degradation-products","display_name":"degradation products","score":0.9470000267028809},{"id":"https://openalex.org/keywords/forced-degradation","display_name":"forced degradation","score":0.9660000205039978},{"id":"https://openalex.org/keywords/alkaline-degradation","display_name":"alkaline degradation","score":0.9359999895095825},{"id":"https://openalex.org/keywords/degradation-kinetics","display_name":"degradation kinetics","score":0.6679999828338623},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.5830000042915344},{"id":"https://openalex.org/keywords/quality-control","display_name":"quality control","score":0.6539999842643738},{"id":"https://openalex.org/keywords/stability-testing","display_name":"stability testing","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9505190253257751},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8226655721664429},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.5838655233383179},{"id":"https://openalex.org/C2777682752","wikidata":"https://www.wikidata.org/wiki/Q8564473","display_name":"Forced degradation","level":4,"score":0.5764609575271606},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.5031499266624451},{"id":"https://openalex.org/C3017686574","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"Gradient elution","level":3,"score":0.4755111336708069},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.4685194194316864},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.4225446581840515},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.221969336271286},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07073706388473511},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069446","descriptor_name":"Atazanavir Sulfate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004340","descriptor_name":"Drug Contamination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D017550","descriptor_name":"Spectroscopy, Fourier Transform Infrared","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021241","descriptor_name":"Spectrometry, Mass, Electrospray Ionization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057230","descriptor_name":"Limit of Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jpba.2011.01.002","doi":"https://doi.org/10.1016/j.jpba.2011.01.002","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jpba.2011.01.002","pdf_url":null,"source":{"id":"https://openalex.org/S174893293","display_name":"Journal of Pharmaceutical and Biomedical Analysis","issn_l":"0731-7085","issn":["0731-7085","1873-264X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical and Biomedical Analysis","raw_type":"journal-article"},{"id":"pmid:21316175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21316175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical and biomedical analysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1969991318","https://openalex.org/W1970401854","https://openalex.org/W1977537246","https://openalex.org/W1983553990","https://openalex.org/W1983745989","https://openalex.org/W1990972265","https://openalex.org/W1992349491","https://openalex.org/W1996491002","https://openalex.org/W2006311103","https://openalex.org/W2007672193","https://openalex.org/W2007791992","https://openalex.org/W2009937319","https://openalex.org/W2011626425","https://openalex.org/W2018686325","https://openalex.org/W2021584502","https://openalex.org/W2024773741","https://openalex.org/W2051728808","https://openalex.org/W2062795681","https://openalex.org/W2073470509","https://openalex.org/W2075110706","https://openalex.org/W2084124490","https://openalex.org/W2116734592","https://openalex.org/W2156274995","https://openalex.org/W2332899971","https://openalex.org/W2488395786","https://openalex.org/W2497735451","https://openalex.org/W2505457655","https://openalex.org/W3215022571"],"related_works":["https://openalex.org/W3009198802","https://openalex.org/W4293142663","https://openalex.org/W1969599953","https://openalex.org/W2899138676","https://openalex.org/W2614454420","https://openalex.org/W2746218910","https://openalex.org/W2093721649","https://openalex.org/W4291554766","https://openalex.org/W2028219722","https://openalex.org/W2779397498"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}